While checkpoint molecules such as PDL1 and SIRPα are abundantly present in M2-like TAMs, PDL1 inhibits the proliferation of anti-tumor immune subtypes, while SIRPα interacts with tumor cells, affecting their phagocytic capability (282). Here, SIRPA is linked to neoplasm.